Enzyme Catalytic Activities in Chronic Obstructive Pulmonary Disease

Archives of Medical Research

Volumn 37, Issue 5, 2006, Pages 624-629

  Cepelak, Ivana ^a   Dodig, Slavica ^b   Romic, Dominik ^c   Ruljancic, Nedeljka ^d   Popovic Grle, Sanja ^a   Malic, Ana ^d  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Pediatric Hospital Srebrnjak   (Croatia)

^c University Hospital for Lung Diseases Jordanovac   (Croatia)

^d Sisak I Psihijatrijska Bolnica Sveti Ivan   (Croatia)

Author keywords

Aminotransferases; Chronic obstructive pulmonary disease; Enzyme activity; Serum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; ENZYME; GAMMA GLUTAMYLTRANSFERASE; IPATROTIUM BROMIDE; LACTATE DEHYDROGENASE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; UNCLASSIFIED DRUG;

ADULT; AGED; AMINO ACID METABOLISM; ARTICLE; CATALYSIS; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FORCED EXPIRATORY VOLUME; HUMAN; MALE; SERUM; SKELETAL MUSCLE; SMOKING; TRANSAMINATION;

ADULT; AGED; AGED, 80 AND OVER; ANOXIA; BIOLOGICAL MARKERS; BONE REMODELING; ENZYMES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 33646878812     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2006.01.004     Document Type: Article

References (49)

1. Wouters E.F.M. Local and systemic inflammation in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 26-33
2. Pauwels R.A., Buist A.S., Calverley P.M., Jenkins C.R., and Hurd S.S. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 163 (2001) 256-276
3. Hageman G.J., Larik I., Pennings H.J., Haenen G.R., Wouters E.F., and Bast A. Systemic poly(ADP-riboza) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radic Biol Med 35 (2003) 140-148
4. Rahman I., Morrison D., Donaldson K., and MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154 (1996) 1055-1060
5. Cebio M.G., and Guerassimor A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med 160 (1999) S21-S25
6. Noguera A., Sala E., Batle S., Iglesias J., Pons A.R., and Augusti A.G.N. Apoptosis and activation of peripheral blood neutrophils in chronic obstructive pulmonary disease. Eur Respir J 16 (2001) 74S
7. Schols A.M. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 6 (2000) 110-115
8. Engelen M.P., Wouters E.F., Dentz N.E., Does J.D., and Schols A.M. Effects of exercise on amino acid metabolism in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 859-864
9. Gasker H.R., Wouters E.F.M., and Van der Vusse G.J. Skeletal muscle dysfunction in COPD and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 71 (2000) 1033-1047
10. Incalzi R.A., Caradonna P., Ranieri P., Basso S., Fuso L., Pagano F., et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 94 (2000) 1079-1084
11. Hunningkake D.B. Cardiovascular disease in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 44-49
12. Wagene E.J., Huibers M.J., and Van Schayck C.P. Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression. Thorax 56 (2001) 587-588
13. Anon. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society. Am J Respir Crit Care Med 159 (1999) S1-S40
14. Griffiths T.L., Burr M.L., Campbell I.A., Lewis-Jenkins V., Mullins J., Schiels K., et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation. A randomised controlled trial. Lancet 355 (2000) 362-368
15. Augusti A.G.N., Noguera A., Sauleda J., Sala E., Pons J., and Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21 (2003) 347-360
16. Wouters E.F.M. Nutrition and metabolism in COPD. Chest 117 (2000) 274S-280S
17. Howald H., Pette D., Simoneau J.A., Uber A., Hoppeler H., and Cerretelli P. Effect of chronic hypoxia on muscle enzyme activities. Int J Sports Med 11 (1990) 510-514
18. Augusti A.G.N. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2 (2005) 367-370
19. Augusti A., Morla M., Salueda J., Sons C., and Busquets X. NF-kappaB activation and iNOS upregulation in skeletal muscle of patients with COPD and low body weight. Thorax 59 (2004) 483-487
20. Mador M., and Bozkanat E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. Respir Res 2 (2001) 216-224
21. Cucina A., Sapienza P., Corvino V., Borelli V., Mariani V., Randone B., et al. Nicotine-induced smooth muscle cell proliferation is mediated through bFGF and TGF-beta1. Surgery 127 (2000) 316-322
22. Bergmeyer H.U., Harder M., and Rej R. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section approved recommendation (1985) of IFCC methods for the measurement of catalytic concentration of enzymes. Part 2. IFCC method for aspartate aminotransferase. J Clin Chem Clin Biochem 24 (1986) 497-510
23. Bergmeyer H.U., Harder M., and Rej R. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section approved recommendation (1985) of IFCC methods for the measurement of catalytic concentration of enzymes. Part 3. IFCC method for alanine aminotransferase. J Clin Chem Clin Biochem 24 (1986) 481-495
24. Tietz N.W., Rinker A.D., and Shaw L.M. IFCC Methods for the measurement of catalytic concentration of enzymes. Part 5. IFCC method for alkaline phosphatase. J Clin Chem Clin Biochem 21 (1983) 731-748
25. Shaw L.M., Stromme H., London L., and Theodorsen L. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section approved recommendation (1985) of IFCC methods for the measurement of catalytic concentration of enzymes. Part 4. IFCC method for gamma-glutamyltransferase. J Clin Chem Clin Biochem 21 (1986) 633-646
26. Bais R., and Philcox M. Approved recommendation on IFCC methods for the measurement of catalytic concentration of enzymes. Part 8. IFCC method for lactate dehydrogenase. Eur J Clin Chem Clin Biochem 32 (1994) 639-655
27. Mathworld, 2005 July 17. Available at: http://mathworld.wolfram.com
28. MedCalc for Windows-Statistical software for biomedical research, also including ROC curve analysis, method comparison and quality control tools. 2005 September 1. Available at: http://www.medcalc.be/
29. Piquette C.A., Rennard S.I., and Sinder G.L. Chronic bronchitis and emphysema. In: Murray J.F., and Nadel J.A. (Eds). Textbook of Respiratory Medicine Vol. 2 (2000), WB Saunders, Philadelphia 1187-1245
30. Wouters E.F. Chronic obstructive pulmonary disease 5. Thorax 57 (2002) 1067-1070
31. Casaburi R. Skeletal muscle function in COPD. Chest 117 Suppl.1 (2000) 267S-271S
32. Schols A.M., Mostert R., Soeters P.B., and Wouters E.F. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax 46 (1991) 695-699
33. Debigare R., Cote C.H., and Maltais F. Peripheral muscle wasting in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1712-1717
34. Spurzem J.R., and Rennard S.I. Pathogenesis of COPD. Semin Respir Crit Care Med 26 (2005) 142-153
35. Eid A.A., Ionescu A.A., Nixon L.S., Lewis-Jenkins V., Matthews S.B., Griffiths T.L., et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164 (2001) 1414-1418
36. Reid M.B. COPD as a muscle disease. Am J Respir Crit Care Med 164 (2001) 1101-1102
37. Jagoe R.T., and Engelen M.P.K.J. Muscle wasting and changes in muscle protein metabolism in chronic obstructive pulmonary disease. Eur Respir J 22 Suppl.46 (2003) 52s-63s
38. Engelen M.P., Schols A.M.W.J., Heidendal G.A.K., and Wouters E.F.M. Exercise-induced lactate increase in relation to muscle substrates in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 162 (2000) 1697-1704
39. Pouw E.M., Schols A.M.W.J., Deutz N.E., and Wouters F.M. Plasma and muscle amino acid levels in relation to resting energy expenditure and inflammation in stable chronic obstructive pulmonary disease. Am J Respir Rit Care Med 158 (1998) 797-801
40. Maltais F., LeBlanc P., Simard C., Jobin J., Berube C., Bruneau J., et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 154 (1996) 442-447
41. Gea J.G., Pasto M., Carmona M.A., Orozco-Levi M., Palomeque J., and Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17 (2001) 39-45
42. Schols A.M.W.J., Deutz N.E.P., Mostert R., and Wouters E.F.M. Plasma amino acid levels in patient with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 48 (1993) 546
43. Salvaggio A., Periti M., Miano L., Tavanelli M., and Marzorati D. Body mass index and liver enzyme activity in serum. Clin Chem 37 5 (1991) 720-723
44. Ramesh V., Saraswat S., Choudhury N., and Gupta R.K. Relationship of serum alanineaminotransferase (ALT) to body mass index (BMI) in blood donors: the need to correct ALT for BMI in blood donor screening. Transfus Med 5 (1995) 273-274
45. Whitefield J.B. Gamma glutamyltransferase. Crit Rev Clin Lab Sci 38 (2001) 263-355
46. Ionescu A.A., and Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 22 (2003) 64s-75s
47. Bolton C.E., Ionescu A.A., Shiels K.M., Pettit R.J., Edwards P.H., Stone M.D., et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 1286-1293
48. Dinc M., Tchugunova Y., Dinc S., Cinarli B., Atasever T., and Oz M. Decreased osteocalcin levels in patients with chronic obstructive pulmonary disease using long-term inhaled beclomethasone dipropionate. Meatbolism 50 (2001) 1336-1339
49. De Vries F., van Staa T.P., Bracke M.S.G.M., Cooper C., Leufknes H.G.M., and Lammers J.W.J. Severity of obstructive airway disease and risk of osteoporotic fracture. Eur Respir J 25 (2005) 879-884